Genetics Generation Advancement Other Current Liabilities

Genetics Generation Advancement posts a other current liabilities of $46M as of June 2026. That compares with $140M in the prior-year period — down 65.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Genetics Generation Advancement's other current liabilities was $140M. The latest reading is $46M — a 65.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Genetics Generation Advancement's financial statement story. At $46M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4160.TWO's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Genetics Generation Advancement's other metric pages and overview cover the third.